v3.22.2.2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (1,577,338) $ (2,378,157)
Adjustments to reconcile net loss to net cash and cash equivalents from operating activities:    
Depreciation and amortization 187,036 219,438
Stock-based compensation expense 175,779 389,085
Value of common stock issued in exchange for consulting services 61,250
Changes in operating assets and liabilities which used cash:    
Accounts receivable (51,531) 28,195
Prepaid expenses and other assets 399,281 125,999
Accounts payable (88,381) 92,651
Accrued compensation 48,076 210,820
Deferred revenue (1,002) 76,114
Accrued and other liabilities 37,064 26,483
Net cash and cash equivalents used in operating activities (809,766) (1,209,372)
Cash Flows from Investing Activities    
Purchase of property and equipment (2,861) (5,747)
Investment in capitalized software (109,537) (267,400)
Net cash and cash equivalents used in investing activities (112,398) (273,147)
Cash Flows from Financing Activity    
Issuance of common stock - net of issuance costs 1,850,501 1,360,000
Net cash and cash equivalents provided by financing activity 1,850,501 1,360,000
Net Increase (Decrease) in Cash and Cash Equivalents 928,337 (122,519)
Cash and Cash Equivalents - Beginning of period 7,155,367 10,713,091
Cash and Cash Equivalents - End of period 8,083,704 10,590,572
Significant Noncash Transactions:    
Acquisition of capitalized software included in accounts payable and accrued liabilities 72,853
Issuance of common stock in exchange for consulting services $ 61,250

Source